Skip to content

Insider · CIK 0001919798

Michael David Katz M.D.

director

Files at HNVR (Hanover Bancorp, Inc. /NY). First filing Dec 11, 2024, latest Dec 11, 2024.

In brief

Michael David Katz M.D. files SEC Form 4 as director at HNVR (Hanover Bancorp, Inc. /NY). Since Dec 11, 2024, Michael David Katz M.D. has reported 0 open-market buys worth $0 and 1 open-market sell worth $128k, the latest filed on Dec 11, 2024.

A track record needs three past buys with six months of prices behind them; Michael David Katz M.D. has 0, so none is measured yet.

The newest scored trade: sold $128k of HNVR on Dec 10, 2024, filed Dec 11, 2024, scored 34 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $128k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

HNVR: Hanover Bancorp, Inc. /NY

HNVROct 12, 2026 · close 24.94

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
34Weak
HNVRsell 2
Hanover Bancorp, Inc. /NY
$128k
5,000 shares
-3%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 10, 2024 HNVR
Hanover Bancorp, Inc. /NY
5,000
0.07% of outstanding
$128kDec 10, 2024none

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 5, 2026HNVR
Hanover Bancorp, Inc. /NY
AGrant or award
Common Stock
+1,592$0.00$0152,202Feb 9, 2026
Jan 29, 2025HNVR
Hanover Bancorp, Inc. /NY
AGrant or award
Common Stock
+1,331$0.00$0150,610Jan 31, 2025
Dec 10, 2024HNVR
Hanover Bancorp, Inc. /NY
SOpen-market sale
Common Stock
-5,000$25.53$128k149,279Dec 11, 2024

Questions about Michael David Katz M.D.

Answered from the filings on this page, as of the latest one.

Is Michael David Katz M.D. buying or selling?

Not in the last 12 months. Michael David Katz M.D.'s latest open-market trade on SEC Form 4 was sold $128k of HNVR on Dec 10, 2024.

How did Michael David Katz M.D.'s past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael David Katz M.D. has 0.

Where does Michael David Katz M.D. file Form 4?

Michael David Katz M.D. has filed Form 4 at HNVR (Hanover Bancorp, Inc. /NY). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael David Katz M.D.: insider trades and track record | InsiderTell